Back
Nxera Pharma Vs. Takeda Pharmaceutical Industry Stock Comparison
Sell
50
SOLTF
Nxera Pharma
Last Price:
8.05
Seasonality Move:
18.65%
Sell
24
TAK
Takeda Pharmaceutical
Last Price:
13.58
Seasonality Move:
5.04%
Sell
50
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $8.05. The Score for SOLTF is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
24
Takeda Pharmaceutical (TAK)
is a Sell
Is Takeda Pharmaceutical a Buy, Sell or Hold?
- The current Takeda Pharmaceutical [TAK] share price is $13.44. The Score for TAK is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- TAK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $8.05
The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.
TAK Stock Price Chart
What is Takeda Pharmaceutical's stock price today?
-
The Takeda Pharmaceutical share price today is $13.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TAK is experiencing slight buying pressure.
SOLTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 52.73 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.43 - 8.09) | Buy |
| Bollinger Bands (100): | (7.96 - 10.08) | Sell |
TAK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 39.58 | Sell |
| Chaikin Money Flow: | 355398 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.46 - 13.92) | Sell |
| Bollinger Bands (100): | (13.55 - 14.67) | Sell |
SOLTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.05 | Sell |
| 20-day SMA: | 7.85 | Buy |
| 50-day SMA: | 8.27 | Sell |
| 200-day SMA: | 9.38 | Sell |
| 8-day EMA: | 8.03 | Buy |
| 20-day EMA: | 7.97 | Buy |
| 50-day EMA: | 8.23 | Sell |
| 200-day EMA: | 9.35 | Sell |
TAK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.46 | Sell |
| 20-day SMA: | 13.68 | Sell |
| 50-day SMA: | 14.06 | Sell |
| 200-day SMA: | 13.88 | Sell |
| 8-day EMA: | 13.47 | Sell |
| 20-day EMA: | 13.64 | Sell |
| 50-day EMA: | 13.9 | Sell |
| 200-day EMA: | 14.05 | Sell |
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Takeda Pharmaceutical Earnings Growth & TAK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Takeda Pharmaceutical Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||